Miren Gaztanaga - Publications

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

Journal: Clinical and translational radiation oncology

Published: June 09, 2026

MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes.

Journal: Clinical and translational radiation oncology

Published: May 10, 2026

Long-term outcomes of real-time TRUS-guided HDR brachytherapy monotherapy for low and favorable intermediate-risk prostate cancer and predictive value of PSA nadir.

Journal: Brachytherapy

Published: February 13, 2026

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 01, 2025

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.

Journal: Biomedicines

Published: July 18, 2025

Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?

Journal: Cancers

Published: March 10, 2025

Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 06, 2024

Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I-II trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 11, 2021

Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report.

Journal: International journal of radiation oncology, biology, physics

Published: September 09, 2020

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery.

Journal: Brachytherapy

Published: November 13, 2017

Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion.

Journal: Brachytherapy

Published: November 21, 2013

Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.

Journal: Brachytherapy

Published: May 22, 2013